As the world is struggling to contain the novel coronavirus (COVID-19) outbreak, healthcare infrastructure and testing capacity have emerged as major issues. There is an urgent need for access to accurate and standardized diagnostics for SARS-CoV-2 (the causative agent of COVID-19). Laboratory testing for COVID-19 and the associated SARS-CoV-2 virus includes methods that detect the presence of the virus (PCR technology) and those that detect antibodies produced in response to infection. Detection of antibodies (serology) can be used both for clinical purposes and population surveillance. AdipoGen Life Sciences has an ongoing pipeline for detection of soluble ACE2, antibodies against SARS-CoV-2 and a HTS detection kit for the determination of SARS-CoV-2 blocking reagents.
LITERATURE REFERENCES:
- Detection of antibodies against SARS-CoV-2 in patients with COVID-19: Z. Du, et al.; J. Med. Virol. (Epub ahead of print) (2020)
Originally posted on adipogen.com/covid-19
Caltag Medsystems is the distributor of Adipogen products in the UK and Ireland. If you have any questions about these products, please contact us.
Related Blogs:
- Highly Specific SARS-CoV-2 Neutralising Antibodies Detection Kit
- Neutralising Antibody Detection Kits for SARS-CoV-2 Variants
- New & Unique SARS-CoV-2 (Spike RBD) IgG Serological ELISA Kit
- New SARS-CoV-2 Inhibitor Screening Kit
- New ACE2 (human) ELISA Kit
- NEW Active & Stable Trimeric SARS-CoV-2 Protein
- Validated Recombinant Proteins for ACE2 & COVID-19 Research
- UNIQUE Human ACE2 Monoclonal Blocking Antibody
- Flow Cytometry-Competent Human ACE2 Monoclonal Antibodies
- All Human ACE2 Antibodies
- New SARS-CoV-2 Recombinant Antibodies